Forte Biosciences Inc — movimiento de fondos (NASDAQ:FBRX) | MetaTrader

Ver el calendario completo

Financials

Visión general Informes Estadísticas

Flujo de caja de las actividades operativas -18.42 M-16.68 M-8.19 M-28.71 M-30.75 M-50.88 M -50.88 M Flujo de caja de las actividades de inversión 3.58 M3.58 M—47 K-35.99 M36.23 M 36.23 M Flujo de caja de las actividades financieras 66.67 M-44 K7.24 M24.68 M51.86 M69.36 M 69.36 M Flujo de caja libre -18.42 M-16.68 M-8.19 M-28.79 M-30.78 M-51 M -51 M

Noticias

Forte Biosciences: 2026 Is Major Inflection Point For FB102 (NASDAQ:FBRX)

Forte Biosciences: Bull Run Could Continue Thanks To Near-Term Data Readouts

Forte Biosciences fija oferta de acciones de 150 millones de dólares a 26,27 dólares por acción

Forte Biosciences lanza oferta pública de acciones

Guggenheim reitera calificación de acciones de Forte Biosciences

Forte Biosciences (FBRX) Upgraded to Buy: Here's What You Should Know

Micron, Insmed among market cap stock movers on Thursday

Evercore ISI inicia cobertura de Forte Biosciences con calificación Outperform

Evercore ISI initiates coverage on Forte Biosciences stock with Outperform rating

Guggenheim initiates Forte Biosciences stock with Buy rating on autoimmune therapy potential

Forte Biosciences Announces Pricing of $75 Million Public Offering

Forte Biosciences Stock (FBRX) Surges 25% on Positive Celiac Disease Trial Data - TipRanks.com